BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 21824448)

  • 41. Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport.
    Yamazaki M; Li B; Louie SW; Pudvah NT; Stocco R; Wong W; Abramovitz M; Demartis A; Laufer R; Hochman JH; Prueksaritanont T; Lin JH
    Xenobiotica; 2005 Jul; 35(7):737-53. PubMed ID: 16316932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In Vitro and In Situ Characterization of the Intestinal Absorption of Capilliposide B and Capilliposide C from
    Zhang X; Cheng X; Wu Y; Feng D; Qian Y; Chen L; Yang B; Gu M
    Molecules; 2019 Mar; 24(7):. PubMed ID: 30925820
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
    Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
    J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
    [TBL] [Abstract][Full Text] [Related]  

  • 44. P-gp is involved in the intestinal absorption and biliary excretion of afatinib in vitro and in rats.
    Zhang Y; Wang C; Liu Z; Meng Q; Huo X; Liu Q; Sun P; Yang X; Sun H; Ma X; Liu K
    Pharmacol Rep; 2018 Apr; 70(2):243-250. PubMed ID: 29475007
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in situ study on characterization and mechanism of the intestinal absorption of 2,3,5,4'-tetrahydroxy-stilbene-2-O-β-D-glucoside.
    Wang C; Zhou Y; Gong X; Zheng L; Li Y
    BMC Pharmacol Toxicol; 2020 Jan; 21(1):7. PubMed ID: 31969193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Involvement of P-glycoprotein and multidrug resistance associated protein 1 on the transepithelial transport of a mercaptoacetamide-based histone-deacetylase inhibitor in Caco-2 cells.
    Konsoula Z; Jung M
    Biol Pharm Bull; 2009 Jan; 32(1):74-8. PubMed ID: 19122284
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Induction of human P-glycoprotein in Caco-2 cells: development of a highly sensitive assay system for P-glycoprotein-mediated drug transport.
    Shirasaka Y; Kawasaki M; Sakane T; Omatsu H; Moriya Y; Nakamura T; Sakaeda T; Okumura K; Langguth P; Yamashita S
    Drug Metab Pharmacokinet; 2006 Oct; 21(5):414-23. PubMed ID: 17072095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Breast Cancer Resistance Protein and Multidrug Resistance Protein 2 Determine the Disposition of Esculetin-7-O-Glucuronide and 4-Methylesculetin-7-O-Glucuronide.
    Li Y; Song W; Ou X; Luo G; Xie Y; Sun R; Wang Y; Qi X; Hu M; Liu Z; Zhu L
    Drug Metab Dispos; 2019 Mar; 47(3):203-214. PubMed ID: 30602435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A functional assay for quantitation of the apparent affinities of ligands of P-glycoprotein in Caco-2 cells.
    Gao J; Murase O; Schowen RL; Aubé J; Borchardt RT
    Pharm Res; 2001 Feb; 18(2):171-6. PubMed ID: 11405287
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
    Taub ME; Podila L; Ely D; Almeida I
    Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers.
    Hosoya KI; Kim KJ; Lee VH
    Pharm Res; 1996 Jun; 13(6):885-90. PubMed ID: 8792427
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.
    Dahan A; Amidon GL
    Pharm Res; 2009 Apr; 26(4):883-92. PubMed ID: 19048359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. P-glycoprotein mediates efflux transport of darunavir in human intestinal Caco-2 and ABCB1 gene-transfected renal LLC-PK1 cell lines.
    Fujimoto H; Higuchi M; Watanabe H; Koh Y; Ghosh AK; Mitsuya H; Tanoue N; Hamada A; Saito H
    Biol Pharm Bull; 2009 Sep; 32(9):1588-93. PubMed ID: 19721237
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of drugs and nutrients on transporter gene expression levels in Caco-2 and LS180 intestinal epithelial cell lines.
    Li Q; Sai Y; Kato Y; Tamai I; Tsuji A
    Pharm Res; 2003 Aug; 20(8):1119-24. PubMed ID: 12948007
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Carrier mechanisms involved in the transepithelial transport of bis(POM)-PMEA and its metabolites across Caco-2 monolayers.
    Annaert P; Van Gelder J; Naesens L; De Clercq E; Van den Mooter G; Kinget R; Augustijns P
    Pharm Res; 1998 Aug; 15(8):1168-73. PubMed ID: 9706045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
    Tang F; Horie K; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):765-72. PubMed ID: 12134945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Impact of Breast Cancer Resistance Protein (BCRP/ABCG2) on Drug Transport Across Caco-2 Cell Monolayers.
    Kawahara I; Nishikawa S; Yamamoto A; Kono Y; Fujita T
    Drug Metab Dispos; 2020 Jun; 48(6):491-498. PubMed ID: 32193356
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.
    Makhey VD; Guo A; Norris DA; Hu P; Yan J; Sinko PJ
    Pharm Res; 1998 Aug; 15(8):1160-7. PubMed ID: 9706044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mechanisms of transport and structure-permeability relationship of sulfasalazine and its analogs in Caco-2 cell monolayers.
    Liang E; Proudfoot J; Yazdanian M
    Pharm Res; 2000 Oct; 17(10):1168-74. PubMed ID: 11145220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Active transepithelial transport of irinotecan (CPT-11) and its metabolites by human intestinal Caco-2 cells.
    Yamamoto W; Verweij J; de Bruijn P; de Jonge MJ; Takano H; Nishiyama M; Kurihara M; Sparreboom A
    Anticancer Drugs; 2001 Jun; 12(5):419-32. PubMed ID: 11395570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.